D Young & Co will be offering its next European biotech patent law update on June 25, 2024.  The webinar will be offered at three times:  9:00 am, noon, and 5:00 pm (BST).  D Young & Co European Patent Attorneys Simon O'Brien and Nathaniel Wand will discuss the latest European biotech patent case law developments, including the following:

T 910/21: New purpose of treating the same disease
T 209/22: Novelty-sufficiency squeeze based on clinical trial
T 1255/21: Lack of inventive step in view of clinical trial protocol
T 1252/20: The definition of "substance or composition" in medical use claims
T 1920/21: Limits to "diagnostic method" exclusion

While there is no fee to participate, attendees must register in advance.  Those wishing to register can do so here.